The benign prostatic hyperplasic devices market in Asia Pacific is expected to grow from US$ 484.08 million in 2022 to US$771.09 million by 2028; it is estimated to grow at a CAGR of 8.1% from 2022 to 2028.

The benign prostatic hyperplasic devices market includes many small and big companies, which are adopting various strategies to improve their market shares. These strategies include new product launches, regional expansions, and technological advancements. With continued innovation, benign prostatic hyperplasic devices are becoming safer, and treatments are becoming easier and more effective than ever. This is driving the acceptance of benign prostatic hyperplasic devices across the region. In April 2022, Teleflex Incorporated launched the UroLift System in Japan for treating BPH or enlarged prostate. The system was made available for purchase immediately after the launch. Further, in May 2020, Teleflex Incorporated received National Medical Products Administration (NMPA) approval for its UroLift System for treating BPH in China. In April 2020, Olympus announced the approval of iTind, a nonsurgical medical device, for the minimally invasive surgery of BPH. This is a temporarily urethral opening device that has been given a De Novo classification by the FDA and is a Class II medical device. In July 2020, Sonablate, a global leader in minimally invasive ultrasound technology, received the NMPA clearance for its minimally invasive device to treat BPH. The device was earlier approved for the treatment of local, low- and medium-risk prostate cancer in China. Later, it was approved for the treatment of BPH in the country. The active participation of market players in product innovation and development, and an increase in the approvals of products are likely to fuel the growth of the benign prostatic hyperplasic devices market in Asia Pacific during the forecast period.

Asia Pacific Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Benign Prostatic Hyperplasic Devices Market Segmentation

The Asia Pacific benign prostatic hyperplasic devices market is segmented on the basis of product, procedure type, end user, and country. Based on product, the market is segmented into resectoscopes, urology lasers, radiofrequency ablation devices, prostatic stents, and implants. The resectoscopes segment is expected to hold the largest share of the market in 2022. On the other hand, the urology lasers segment is expected to register the highest CAGR during the forecast period. Based on procedure type, the Asia Pacific benign prostatic hyperplasic devices market is segmented into transurethral microwave therapy, transurethral resection of the prostate, transurethral needle ablation of the prostate, laser surgery, urolift surgery, and others. The transurethral resection of the prostate segment held the largest market share in 2022, and it is also expected to register the highest CAGR in the market during the forecast period. Based on end user, the Asia Pacific benign prostatic hyperplasic devices market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospital segment held the largest market share in 2022, while the clinics segment is expected to register the highest CAGR during the forecast period. Based on country, the Asia Pacific benign prostatic hyperplasic devices market is segmented into China, Japan, India, Australia, South Korea, and Rest of Asia Pacific. In 2022, China held a larger market share. On the other side, and India is expected to register a higher CAGR during the forecast period.

KARL STORZ SE & Co. KG; Olympus Corporation; Boston Scientific Corporation; Teleflex Incorporated; and Richard Wolf GmbH are among the leading companies in the Asia Pacific benign prostatic hyperplasic devices market.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Benign Prostatic Hyperplasic Devices Market – By Product
1.3.2 Asia Pacific Benign Prostatic Hyperplasic Devices Market – By Procedure Type
1.3.3 Asia Pacific Benign Prostatic Hyperplasic Devices Market – By End User
1.3.4 Asia Pacific Benign Prostatic Hyperplasic Devices Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Benign Prostatic Hyperplasic Devices Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Experts Opinion
5. Asia Pacific Benign Prostatic Hyperplasic Devices Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Uplifting Prevalence of Benign Prostatic Hyperplasia along with Growing Risk Factors
5.1.2 Growing Investments, Funds, and Grants for Research in BPH Treatment
5.2 Market Restraints
5.2.1 Limiting Awareness of Prostate Health Among Men
5.3 Market Opportunities
5.3.1 Continuous Emerging Markets
5.4 Future Trends
5.4.1 Higher Product Approvals and Launches
5.5 Impact Analysis
6. Asia Pacific Benign Prostatic Hyperplasic Devices Market Analysis
6.1 Asia Pacific Benign Prostatic Hyperplasic Devices Market Revenue Forecast and Analysis
7. Asia Pacific Benign Prostatic Hyperplasic Devices Market – by Product
7.1 Asia Pacific Benign Prostatic Hyperplasic Devices Market Revenue Share, by Product (2022 and 2028)
7.2 Resectoscopes
7.2.1 Overview
7.2.2 Resectoscopes: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
7.3 Urology Lasers
7.3.1 Overview
7.3.2 Urology Lasers: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Radiofrequency Ablation Devices
7.4.1 Overview
7.4.2 Radiofrequency Ablation Devices: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Prostatic Stents
7.5.1 Overview
7.5.2 Prostatic Stents: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Implants
7.6.1 Overview
7.6.2 Implants: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
8. Asia Pacific Benign Prostatic Hyperplasic Devices Market – by Procedure Type
8.1 Asia Pacific Benign Prostatic Hyperplasic Devices Market Revenue Share, by Procedure Type (2022 and 2028)
8.2 Transurethral Microwave Therapy
8.2.1 Overview
8.2.2 Transurethral Microwave Therapy: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Transurethral Resection of the Prostate
8.3.1 Overview
8.3.2 Transurethral Resection of the Prostate: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Transurethral Needle Ablation of the Prostate
8.4.1 Overview
8.4.2 Transurethral Needle Ablation of the Prostate: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Laser Surgery
8.5.1 Overview
8.5.2 Laser Surgery: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
8.6 UroLift Surgery
8.6.1 Overview
8.6.2 UroLift Surgery: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
9. Asia Pacific Benign Prostatic Hyperplasic Devices Market – by End User
9.1 Overview
9.2 Asia Pacific Benign Prostatic Hyperplasic Devices Market Revenue Share, by End User (2022 and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals Market Revenue and Forecast to 2028 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics Market Revenue and Forecast to 2028 (US$ Million)
9.5 Ambulatory Surgical Centers
9.5.1 Overview
9.5.2 Ambulatory Surgical Centers Market Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)
10. Asia Pacific Benign Prostatic Hyperplasic Devices Market – by Country Analysis
10.1 Overview
10.1.1 Asia Pacific: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)
10.1.1.1 China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.1.1.1.4 China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
10.1.1.1.5 China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
10.1.1.2 Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.1.1.2.4 Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
10.1.1.2.5 Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
10.1.1.3 India Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.1.1.3.4 India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
10.1.1.3.5 India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
10.1.1.4 South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.1.1.4.4 South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
10.1.1.4.5 South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
10.1.1.5 Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3 Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.1.1.5.4 Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
10.1.1.5.5 Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
10.1.1.6 Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3 Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.1.1.6.4 Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
10.1.1.6.5 Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
11. Asia Pacific Benign Prostatic Hyperplasic Devices Market – Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.3 Organic Growth Strategies
12. Company Profiles
12.1 KARL STORZ SE & Co. KG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Richard Wolf GmbH
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Olympus Corporation
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Boston Scientific Corporation
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Teleflex Incorporated
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms for Asia Pacific Benign Prostatic Hyperplasia Devices Market

LIST OF TABLES

Table 1. China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
Table 2. China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
Table 3. China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 4. Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
Table 5. Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
Table 6. Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 7. India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
Table 8. India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
Table 9. India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 10. South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
Table 11. South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
Table 12. South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 13. Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
Table 14. Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
Table 15. Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 16. Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
Table 17. Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
Table 18. Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 19. Recent Inorganic Growth Strategies in the Benign Prostatic Hyperplasia Devices Market
Table 20. Recent Organic Growth Strategies in the Benign Prostatic Hyperplasia Devices Market
Table 21. Glossary of Terms

LIST OF FIGURES

Figure 1. Asia Pacific Benign Prostatic Hyperplasic Devices Market Segmentation
Figure 2. Asia Pacific Benign Prostatic Hyperplasic Devices Market, By Country
Figure 3. Asia Pacific Benign Prostatic Hyperplasic Devices Market Overview
Figure 4. Resectoscopes Segment Held Largest Share of Product Segment in Benign Prostatic Hyperplasic Devices Market
Figure 5. China is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Asia Pacific Benign Prostatic Hyperplasic Devices Market, Industry Landscape
Figure 7. Asia Pacific: PEST Analysis
Figure 8. Experts Opinion
Figure 9. Asia Pacific Benign Prostatic Hyperplasic Devices Market – Revenue Forecast and Analysis – 2020-2028
Figure 10. Asia Pacific Benign Prostatic Hyperplasic Devices Market Revenue Share, by Product (2022 and 2028)
Figure 11. Resectoscopes: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Urology Lasers: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Radiofrequency Ablation Devices: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Prostatic Stents: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Implants: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Asia Pacific Benign Prostatic Hyperplasic Devices Market Revenue Share, by Procedure Type (2022 and 2028)
Figure 17. Transurethral Microwave Therapy: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Transurethral Resection of the Prostate: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Transurethral Needle Ablation of the Prostate: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Laser Surgery: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. UroLift Surgery: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Asia Pacific Benign Prostatic Hyperplasic Devices Market Revenue Share, by End User (2022 and 2028)
Figure 24. Hospitals Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. Clinics Market Revenue and Forecast to 2028 (US$ Million)
Figure 26. Ambulatory Surgical Centers Market Revenue and Forecast to 2028 (US$ Million)
Figure 27. Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 28. Asia Pacific Benign Prostatic Hyperplasic Devices Market Overview, by Country (2021)
Figure 29. Asia Pacific: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)
Figure 30. China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
Figure 31. Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
Figure 32. India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
Figure 33. South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
Figure 34. Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
Figure 35. Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific benign prostatic hyperplasic devices market.
● Highlights key business priorities in order to assist companies to realign their business strategies
● The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific benign prostatic hyperplasic devices market, thereby allowing players across the value chain to develop effective long-term strategies
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
● Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the benign prostatic hyperplasic devices market, as well as those hindering it
● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

The List of Companies – Asia Pacific Benign Prostatic Hyperplasic Devices Market

● KARL STORZ SE & Co. KG
● Olympus Corporation
● Boston Scientific Corporation
● Teleflex Incorporated
● Richard Wolf GmbH
● GmbH